Search Results - "Banki, Eszter"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Protective Effects of PACAP in a Rat Model of Diabetic Neuropathy by Kiss, Peter, Banki, Eszter, Gaszner, Balazs, Nagy, Daniel, Helyes, Zsuzsanna, Pal, Endre, Reman, Gyongyver, Toth, Gabor, Tamas, Andrea, Reglodi, Dora

    “…Pituitary adenylate cyclase-activating peptide (PACAP) is a neuropeptide with a widespread occurrence and diverse effects. PACAP has well-documented neuro- and…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Protective effects of the neuropeptide PACAP in diabetic retinopathy by Szabadfi, Krisztina, Atlasz, Tamas, Kiss, Peter, Reglodi, Dora, Szabo, Aliz, Kovacs, Krisztina, Szalontai, Balint, Setalo, Gyorgy, Jr, Banki, Eszter, Csanaky, Katalin, Tamas, Andrea, Gabriel, Robert

    Published in Cell and tissue research (01-04-2012)
    “…Pituitary adenylate cyclase activating polypeptide (PACAP) is a neuropeptide with highly potent neurotrophic and neuroprotective effects. PACAP and its…”
    Get full text
    Journal Article
  4. 4

    Characterization of the Thermoregulatory Response to Pituitary Adenylate Cyclase-Activating Polypeptide in Rodents by Banki, Eszter, Pakai, Eszter, Gaszner, Balazs, Zsiboras, Csaba, Czett, Andras, Bhuddi, Paras Rahul Parkash, Hashimoto, Hitoshi, Toth, Gabor, Tamas, Andrea, Reglodi, Dora, Garami, Andras

    Published in Journal of molecular neuroscience (01-11-2014)
    “…Administration of the long form (38 amino acids) of pituitary adenylate cyclase-activating polypeptide (PACAP38) into the central nervous system causes…”
    Get full text
    Journal Article
  5. 5

    Molecular Mechanisms Underlying the Nephroprotective Effects of PACAP in Diabetes by Banki, Eszter, Kovacs, Krisztina, Nagy, Daniel, Juhasz, Tamas, Degrell, Peter, Csanaky, Katalin, Kiss, Peter, Jancso, Gabor, Toth, Gabor, Tamas, Andrea, Reglodi, Dora

    Published in Journal of molecular neuroscience (01-11-2014)
    “…Diabetic nephropathy is the leading cause of end-stage renal failure and accounts for 30–40 % of patients entering renal transplant programmes. The…”
    Get full text
    Journal Article
  6. 6

    Presence of pituitary adenylate cyclase activating polypeptide-38 in human plasma and milk by Borzsei, Rita, Mark, Laszlo, Tamas, Andrea, Bagoly, Terez, Bay, Csaba, Csanaky, Katalin, Banki, Eszter, Kiss, Peter, Vaczy, Alexandra, Horvath, Gabriella, Nemeth, Jozsef, Szauer, Edit, Helyes, Zsuzsanna, Reglodi, Dora

    Published in European journal of endocrinology (01-04-2009)
    “…ObjectivePituitary adenylate cyclase activating polypeptide (PACAP) is a pleiotropic and multifunctional neuropeptide widely distributed throughout the body…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Changes in PACAP Immunoreactivity in Human Milk and Presence of PAC1 Receptor in Mammary Gland during Lactation by Csanaky, Katalin, Banki, Eszter, Szabadfi, Krisztina, Reglodi, Dora, Tarcai, Ibolya, Czegledi, Levente, Helyes, Zsuzsanna, Ertl, Tibor, Gyarmati, Judit, Szanto, Zalan, Zapf, Istvan, Sipos, Erika, Shioda, Seiji, Tamas, Andrea

    Published in Journal of molecular neuroscience (01-11-2012)
    “…Pituitary adenylate cyclase-activating polypeptide (PACAP) is a neuropeptide with widespread occurrence in the nervous system and peripheral organs, including…”
    Get full text
    Journal Article
  12. 12

    A PACAP és a PACAP Receptorok Szerepének Vizsgálata Diabeteses Nephropathia és Neurogén Gyulladás Állatmodelljében by Bánki, Eszter Márta

    Published 01-01-2014
    “…Ph.D. munkám első részében a PACAP diabeteses nephropathiában kifejtett hatását vizsgáltam szövettani és molekuláris biológiai vizsgálatok segítségével…”
    Get full text
    Dissertation